[HTML][HTML] Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective

N Ebrahimi, Z Yousefi, G Khosravi, FE Malayeri… - Frontiers in …, 2023 - frontiersin.org
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

[HTML][HTML] Implementation strategies used to increase human papillomavirus vaccination uptake by adolescent girls in Sub-Saharan Africa: a scoping review

MK Lubeya, M Mwanahamuntu, CJ Chibwesha… - Vaccines, 2023 - mdpi.com
Barriers to successful implementation of the human papillomavirus vaccination exist.
However, there is limited evidence on implementation strategies in sub-Saharan Africa …

[HTML][HTML] Implementation of COVID-19 vaccination services in prison in six European countries: translating emergency intervention into routine life-course vaccination

S Mazzilli, N Cocco, D Petri, B Moazen, A Rosello… - BMC Public Health, 2024 - Springer
Background Evidence has shown that the risk of transmission of SARS-CoV-2 is much
higher in prisons than in the community. The release of the COVID-19 vaccine and the …

[HTML][HTML] Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020

RH Doshi, RM Casey, N Adrien, A Ndiaye… - PLOS Global Public …, 2022 - journals.plos.org
In Senegal, cervical cancer is the most common cancer among women and the leading
cause of morbidity and mortality from all cancers. In 2018, Senegal launched a national …

[HTML][HTML] Human Papillomavirus Vaccination Acceleration and Introduction in Sub-Saharan Africa: A Multi-Country Cohort Analysis

GC Adeyanju, TA Essoh, AR Sidibe, F Kyesi, M Aina - Vaccines, 2024 - mdpi.com
Background: Cervical cancer, caused by human papillomavirus (HPV) infection, is the
second-largest cancer killer of women in low-and middle-income countries. The brunt of the …

[HTML][HTML] Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource …

DEN Waheed, A Bolio, D Guillaume, A Sidibe… - Frontiers in Public …, 2023 - frontiersin.org
Cervical cancer due to human papillomavirus (HPV) infection is a leading cause of mortality
among women in low-resource settings. Many Sub-Saharan African countries have …

HPV Vaccine Access and Cervical Cancer Policymaking Process: A Comparative Governmental Priority Setting Study of Ghana, Rwanda, and Canada

E Asempah - 2023 - yorkspace.library.yorku.ca
Cervical cancer is a global health issue that claims over 600,000 lives yearly. While high-
income countries (HICs) record lower incidence rates of cervical cancer, the opposite is true …

The Effect of Carvacrol on the Expression of Genes Hmox-1, iNOS, Nrf2 and NF-ҚB in the Spinal Cord of Experimental Autoimmune Encephalomyelitis Mice

N Ebrahimi, Z Yousefi, G Khosravi, MH Shams - Front Immunol, 2023 - eprints.lums.ac.ir
Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

Pregnancy and cervical cancer: a retrospective study of the associations of age at first pregnancy and parity with non-invasive and invasive cervical lesions among …

M Bah - 2023 - search.proquest.com
Cervical cancer is the leading cause of cancer-related deaths in Senegal. Senegal's cervical
cancer prevention strategy has prioritized vaccinating young girls with human …

[图书][B] Human Papillomavirus prevalence in Senegalese women in relation with age

A Garayusifova - 2022 - search.proquest.com
Background: Senegal has high cervical cancer incidence rates of 34.7 per 100,000 women-
years, disproportionately affecting women at different ages. Data on age-specific HPV …